We assessed the impact of infectious disease (ID) consultation on management and outcome in patients with Staphylococcus aureus bacteremia (SAB).
Staphylococcus aureus bacteremia (SAB) is a leading bloodstream infection with 10%-30% mortality [1] [2] [3] [4] [5] . Based on published guidelines and observational studies, SAB management standards include repeat blood culture, echocardiography, removal of infectious foci, and early empiric antibiotic therapy, as well as intravenous antibiotic therapy of ≥14 days for uncomplicated bacteremia and ≥28 days for complicated bacteremia [6] [7] [8] [9] [10] [11] .
The value of specialist involvement on management and outcome of many medical conditions including acute kidney injury, myocardial infarction, congestive heart failure, and chronic obstructive pulmonary disease is well established [12] [13] [14] [15] . Likewise, infectious disease (ID) specialists may be useful in guiding SAB management. ID consultation is associated with adherence to the aforementioned management standards [1, [16] [17] [18] [19] [20] [21] [22] [23] [24] . In some studies, ID consultation did not significantly decrease mortality after adjusting for other variables [1, 4, 6, 22, 25] . In other studies, ID specialist consultation improved survival [16-21, 23, 24, 26-28] . However, the most recent review described the current evidence on ID consultation as low quality [29] . First, these studies were conducted at single tertiary academic centers and most had relatively small sample sizes, making their results less generalizable [16-21, 23, 24, 26-28] . Second, although the allocation of ID consultation may be biased, no study adjusted for all measurable covariates that may affect assignment of ID consultation and reported a significant impact of ID consultation on mortality. Last, no study examined length of stay (LOS) in hospital while accounting for death in hospital as a competing event.
We conducted a retrospective cohort study to assess the impact of ID specialist consultation on in-hospital mortality, LOS, and quality of care in patients with SAB using multivariable modeling and matched propensity score analysis.
METHODS

Study Design
We conducted a retrospective cohort study at 6 acute care academic and community hospitals in the Greater Toronto Area, which accounted for a total of 2968 acute care beds and 145 000 annual patient admissions. Consecutive patients were included in the analysis from 1 April 2007 to 31 March 2010. Research ethics board approval was obtained from each institution.
Patient records were included if the patient had at least 1 positive blood culture for S. aureus as identified in microbiology computerized database at all 6 sites, where all selected patient files were analyzed. Identification of S. aureus and antimicrobial susceptibility testing of blood culture were based on Clinical and Laboratory Standards Institute guidelines [30] .
Patients <18 years of age were excluded from analysis. Additionally, patients were excluded from analysis if any of the following occurred within 2 days of blood culture: death, discharge to another institution, left against medical advice, or deemed palliative (specifically not undergoing any investigation or medical therapy). The threshold of 2 days was chosen because >90% of blood culture returned a positive S. aureus result within 2 days and it allowed adequate time for ID consultation [1] .
Data Collection
Data were obtained from patients' electronic and paper medical records at each site and entered into a standardized case report form. Collected data included patient demographics, comorbidities, microbiological data, antibiotic treatment, investigations, removal of infectious foci, and clinical outcomes.
Patient Characteristics and SAB Clinical Characteristics
Infection acquisition was deemed nosocomial, healthcareassociated, or community-acquired based on standard definitions [31] . Patients were assumed to have community-acquired infection unless proven otherwise.
High-and intermediate-risk cardiac conditions were defined according to American Heart Association guidelines for infective endocarditis [32] . Immune suppression was defined as high-dose corticosteroid (>10 mg prednisone or equivalent), human immunodeficiency virus/AIDS, chemotherapy within last 6 weeks, neutropenia within 72 hours of bacteremia, or transplantation requiring immunosuppressive therapy.
Renal insufficiency was defined as serum creatinine level >177 µmol/L within 24 hours of bacteremia. Early infectious foci were defined as documented foci preceding or within 2 days of blood culture collection, whereas late infectious foci were defined as documented foci after 2 days following blood culture collection. Endocarditis was adjudicated using the modified Duke criteria [33] .
Uncomplicated SAB was defined as no deep tissue infection, no metastatic infection, and no endocarditis [6, 7, 19] . Complicated SAB was defined as endocarditis, deep tissue infection, or metastatic infection [6, 7, 19] .
Quality Measures of Management
For antibiotic therapy to be considered appropriate, it had to be administered intravenously. For methicillin-susceptible S. aureus (MSSA), appropriate antibiotics included β-lactams (cloxacillin, nafcillin, cefazolin, piperacillin-tazobactam, ticarcillinclavulanate, amoxicillin-clavulanate, and penicillin if susceptible), quinupristin-dalfopristin, daptomycin, and vancomycin. For methicillin-resistant S. aureus (MRSA), appropriate antibiotics included vancomycin, quinupristin-dalfopristin, and daptomycin. Duration of antibiotic was calculated from start of appropriate antibiotic closest to blood culture collection date. For patients who were discharged alive, the planned treatment stop date was considered the last day of appropriate antibiotics.
Empiric therapy was defined as any appropriate antibiotic started within 3 days of blood culture collection. The threshold of 3 days was chosen, because >90% of blood culture reported susceptibility as MSSA or MRSA within 3 days. Definitive antibiotic therapy was defined as any appropriate antibiotic started or continued past 4 days since blood culture collection, allowing 1 day after susceptibility report to switch antibiotics.
Appropriate antibiotic duration was defined as ≥14 days for uncomplicated and ≥28 days for complicated SAB [6, 7, 19] .
ID Consultation
At all sites, ID service consultation was available and optional. There were 29 consultants at 6 sites. All had full accreditation in ID from the Royal College of Physicians and Surgeons of Canada. At 3 sites, the microbiology laboratory notified the ID service when blood culture was positive for S. aureus, and an ID consultation was offered to the most responsible physician as per departmental policy. However, these ID consultations were not mandatory. In all other sites, ID consultation was done based on request from the most responsible physician.
ID consultation was defined as a formal ID consultation documented in the patient chart within 7 days of blood culture collection or having an ID specialist as the most responsible physician.
Outcome
Primary outcome was in-hospital mortality within 90 days. All patient outcomes were followed until death in hospital or 90 days, whichever came first. LOS was calculated as time from blood culture collection to discharge or death in hospital.
Statistical Analysis
Comparison between ID consultation and no ID consultation groups were done with Wilcoxon rank-sum test for nonnormally distributed continuous variables and Fisher exact test for categorical variables.
A competing risk model was used to describe in-hospital mortality and time to discharge, where possible endpoints included alive in-hospital by day 90, deceased in-hospital, and discharged alive. Based on a cumulative incidence function, a subdistribution hazard ratio (sHR) was calculated using the Fine and Gray model [34] . In the univariate analysis, patient baseline characteristics and SAB clinical characteristics with the exception of variables beyond 2 days were considered potential predictors. All predictors with P < .2 on univariate analysis were included in the final multivariable Fine and Gray model along with ID consultation.
Propensity score for ID consultation was estimated using a logistic regression of all patient baseline characteristics and SAB clinical characteristics with the exception of variables beyond 2 days. Patients without ID consultation were matched in a 1:1 ratio to patients with ID consultation using nearest neighbor matching with specified caliper width of 0.55 times the standard deviation of the logit of propensity scores. The matched groups were compared with the Fine and Gray model in terms of inhospital mortality and being discharged alive.
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Comorbidity High-risk cardiac condition 73 (9) 51 (10) 22 (6) .0800 Intermediate-risk cardiac condition 18 (2) 12 (2) 6 (2) .6327
Myocardial infarction 166 (20) 103 (20) 63 (18) .5371
Congestive heart failure 171 (20) 96 (19) 75 (22) .2956 Peripheral vascular disease 77 (9) 56 (11) 21 (6) .0149
Chronic pulmonary disease 82 (10) 57 (11) 25 (7) .0590
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RESULTS
General Cohort and ID Consultation
Of 969 patients with SAB, 847 patients were eligible for the study, including 506 (60%) patients in the ID consultation (IDC) group and 341 (40%) patients in the no ID consultation (NIDC) group (Figure 1 ). The proportion of ID consultation ranged from 43% to 80% for different sites. Within the IDC group, 476 (94%) patients had a formal ID consultation and 30 (6%) patients had an ID specialist as the most responsible physician. Of 506 ID consultations, 346 (68%) were done within 2 days of bacteremia. Of the 29 ID specialists, from ID certification to start of study, 9 (31%) had ≤5 years, 5 (17%) had 6-10 years, 5 (17%) had 11-15 years, 2 (7%) had 16-20 years, and 8 (28%) had >20 years of experience. Patient baseline and SAB clinical characteristics are outlined in Table 1 .
Quality Measures of Management
For IDC patients, ID recommendations are listed in Table 2 .
Compared to NIDC patients, IDC patients were more likely to receive an echocardiogram, a repeat blood culture, appropriate empiric antibiotics, and longer duration of antibiotic therapy (Table 3) . Ninety-two patients had both a transthoracic echocardiogram (TTE) and a transesophageal echocardiogram (TEE) in hospital. Of the 65 patients with both TTE and TEE where the TTE was negative, 12 (18%) patients had a positive TEE for signs of endocarditis.
Antibiotic choices for MSSA and MRSA patients are outlined in Tables 4 and 5 , respectively.
In patients who were alive when their antibiotic therapy ended, 285 of 422 (68%) IDC and 141 of 262 (54%) NIDC patients received antibiotic therapy for an appropriate duration (P = .0004) (Supplementary Appendix Table 1 ). In 357 uncomplicated In patients with central venous catheter (CVC) as an early infectious focus, 59 of 73 (81%) IDC and 49 of 57 (86%) NIDC patients had their catheters removed (P = .4873). In patients with bone or joint infection as an early infectious focus, 46 of 74 (62%) IDC and 6 of 14 (43%) NIDC patients had bone debridement or joint aspiration (P = .2380). In patients with an abscess as an early infectious focus, 25 of 33 (76%) IDC and 4 of 9 (44%) NIDC patients had their abscess drained (P = .1067).
Modeling In-Hospital Mortality and Discharge
In all patients, 204 (24%) patients died in hospital: 104 (21%) IDC and 100 (29%) NIDC patients. Seven patients (<1%) were discharged within 2 days of positive blood culture. None of these 7 patients died in follow-up postdischarge. For all patients, the median LOS was 17.00 days (interquartile range [IQR], 9.00-35.00 days): 16.00 days (IQR, 9.00-33.00 days) for IDC patients and 17.00 days (IQR, 9.00-36.00 days) for NIDC patients. Excluding patients who died in hospital, the median LOS was 16.00 days (IQR, 9.00-35.00 days) for IDC patients and 19.00 days (IQR, 10.00-46.00 days) for NIDC patients.
Relative to no ID consultation, the unadjusted sHR for ID consultation was 0.66 (95% CI, .50-.86; P = .0025) for inhospital mortality and 1.36 (95% CI, 1.15-1.61; P = .0003) for being discharged alive (Figure 2) .
Univariate analysis predicting in-hospital mortality is listed in Supplementary Appendix Table 2 . Multivariable modeling of significant predictors for in-hospital mortality is listed in Supplementary Appendix Table 3 . After adjusting for these predictors in the multivariable model, ID consultation had an sHR for in-hospital mortality of 0.68 (95% CI, .50-.93; P = .0151). Likewise, for predicting time to discharge, univariate analysis and multivariable modeling of significant predictors are listed in Supplementary Appendix Tables 4 and 5, respectively. After adjusting for these predictors in the multivariable model, ID consultation had an sHR for being discharged alive of 1.22 (95% CI, 1.01-1.48; P = .0360).
Propensity Score-Matched Analysis
Based on propensity score, 303 IDC patients were matched with 303 NIDC patients ( Table 6 ). After matching, the maximum standardized difference of mean was <0.10, suggesting that the 2 groups were similar with respect to measured variables.
Comparing the 2 groups matched by propensity score, the sHR for ID consultation was 0.72 for in-hospital mortality (95% CI, .52-.99; P = .0451) and 1.28 for being discharged alive (95% CI, 1.06-1.56; P = .0109) (Supplementary Appendix Figure 1 ). For quality of care measures that apply to all SAB patients, IDC patients were more likely than NIDC patients to receive an echocardiogram, a repeat blood culture, appropriate empiric antibiotic therapy, and longer duration of antibiotic therapy in the propensity score-matched groups (Table 7) . 
DISCUSSION
In our multicenter cohort study, ID consultation was associated with a reduction of in-hospital mortality and increased likelihood of discharge on any given day reflecting shorter LOS, even after adjustment by multivariable modeling or propensity score-matched analysis. The borderline significant propensity score-matched analysis estimate was most likely due to a smaller sample size and consequently wider CI. ID consultation was associated with increased adherence to quality of care measures including repeat blood culture, echocardiography, appropriate empiric antibiotic therapy, and duration of antibiotic therapy in our study. In past studies, these quality of care measures have independently or in combination been associated with better outcomes [6, 21, 35] . Improvement in outcome due to ID consultation is most likely multifactorial. It would be difficult to discern the effect of each ID consultation-resultant change in management on outcome due to relation of one management factor with other management, ID consultation, patient characteristics, survival time, and outcome. Similar speculation of the causal pathway from specialist involvement to changes in management to outcome has been described previously [12] [13] [14] [15] . Our study showed ID consultation being associated with an approximately 30% decrease in in-hospital mortality, less than the estimate of 31%-82% in previous studies [16-21, 23, 24, 26-28] . This difference may be due to numerous reasons. First, we excluded patients who died within 2 days of blood culture. These patients with early death would be less likely to receive an ID consultation and thus increase the difference in mortality between IDC and NIDC patients. Besides our study, only 5 other studies excluded patients who died within ≥2 days of blood culture [19, 21, 23, 24, 28] . Second, our endpoint was in-hospital mortality, whereas other studies used different outcomes such as all-cause mortality and mortality at different time points [18-21, 23, 26, 27] . Third, the overall in-hospital mortality in our study was 24%, which was slightly higher than some studies [16-21, 23, 24, 27] . In contrast to these studies, the higher mortality in our study could be attributed to patients being older and inclusion of community centers. Still, our in-hospital mortality rate was very close to SAB case fatality in a Canadian study [5] . Last, our study included 847 patients, whereas the largest past study included 699 cases from 603 patients [26] . Our larger sample size increases the precision of our estimate.
Our study demonstrates that ID consultation is associated with increased likelihood of repeat blood culture, echocardiography, appropriate empiric antibiotic therapy, and longer duration of antibiotics. These findings were similar to other studies [1, 16-22, 24, 28] . Catheter removal in CVC infections was similar in IDC and NIDC groups, most likely due to it being a widely accepted standard in SAB management. Although not statistically significant, IDC patients had a slightly lower CVC removal rate compared to NIDC patients. Although we did not collect data on tunneled catheters, we speculate that IDC patients who did not have their catheters removed most likely had tunneled catheter where catheter salvage may be attempted, because 6 of 14 (43%) patients in the IDC group with CVC infection without catheter removal had ongoing hemodialysis or chemotherapy. In contrast, 1 of 7 (13%) patients with CVC infection in the NIDC group without catheter removal had ongoing hemodialysis or chemotherapy. Besides catheter removal, ID consultation increased the likelihood of removal of other infectious foci in our study. Unfortunately, penicillin allergy data were incomplete in our study, so we could not evaluate use of β-lactams for MSSA bacteremia as a quality of care measure. Also, we did not collect information on ID recommendation of penicillin skin testing and desensitization for patients with penicillin allergy.
In our multivariable modeling of in-hospital mortality, significant or borderline risk factors for mortality included older age; hospital sites; nosocomial healthcare setting; no intravenous drug use; chronic kidney disease; absence of fever, shock, endocarditis, respiratory infection, and embolic stroke; and no ID consultation. Besides hospital sites and ID consultation, the aforementioned predictors were described as significant predictors of mortality in past studies [36] [37] [38] [39] . This study has several strengths. To our knowledge, our study is the largest study examining the impact of ID consultation on SAB outcomes. The study was conducted across both academic and community hospitals, enhancing its generalizability. The relationship of ID consultation to in-hospital mortality was confirmed using 2 different approaches of multivariable modeling and propensity score-matched analysis, thereby yielding a more robust result. Last, unlike other studies, we used inhospital mortality in a competing risk model as an outcome. In-hospital mortality was more likely to be affected by ID consultation and consequent change in management that all occurred in hospital. Following discharge from hospital, many factors such as follow-up and patient compliance with treatment may affect mortality. Therefore, mortality after hospital discharge may be less likely due to ID consultation that occurred in hospital. The competing risk model can assess and account for both in-hospital mortality and time to discharge, giving a comprehensive and clinically relevant interpretation of both outcomes [40] .
This study also had several limitations. First, the study used data from a retrospective medical records review. However, rigorous and consistent data collection and verification ensured that our data were of high quality and nearly complete. Second, informal curbside ID specialist consultation was not documented in our database. If that were the case, the misclassification would make the 2 groups more similar and the results more conservative in our study. Third, selection bias could be present. ID consultation was most likely to be nonrandom and based on patients' clinical presentation and prognosis. However, ID consultation most likely selected for more severe disease and poorer prognosis, which decreased likelihood of finding a positive effect of ID consultation. To minimize this selection bias, we adjusted for patient and SAB baseline characteristics using multivariable modeling and propensity score matching in our analysis.
Our study adds to a growing body of evidence suggesting that ID consultation optimizes management and improves outcomes in SAB. However, a significant proportion of individuals do not receive ID consultation. A future challenge will be to ensure that all patients benefit from this expert advice and improved care. Considering ID consultation as an intervention, our study shows an unadjusted 8.8% absolute risk reduction of in-hospital mortality, which equates to a number needed to treat of roughly 11. This number needed to treat suggests substantial benefits from mandatory ID consultation, which could be implemented in hospital policies to enhance patient care. A prospective clinical trial is needed to study whether such policies would deliver the anticipated results based on our study and those previously published.
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